ENTITY
SK Bioscience

SK Bioscience (302440 KS)

212
Analysis
Health CareSouth Korea
SK Bioscience Co.,Ltd. operates biopharmaceutical businesses. The Company produces vaccines, sky cellflu prefilled syringes, sky cellflu quadrivalent prefilled syringes, varicella drugs, and other related products. SK Bioscience markets its products throughout South Korea.
more
bullishSK Bioscience
01 Apr 2021 10:47

SK Bioscience: K200 Fast Entry, Lock-Up Expiry, Loan/Short Balance, & Exit Points

This post checks the current situation of SK Bioscience on K200 fast entry, lock-up expiry, loan/short balance, and potential exit points.

Logo
562 Views
Share
bullishSK Bioscience
21 Mar 2021 01:52

What Happened to SK Bioscience on Day 2 (Feat. Kyobo Securities)?

This post looks at the suspicious activities seen at the Kyobo account on SK Biosciences' Day 1 and Day 2 and what it can mean for the price in the...

Logo
357 Views
Share
bullishSK Bioscience
19 Mar 2021 06:29

SK Bioscience to KOSPI 200 Is a Done Deal & A Likely Deletion

This post has the latest update on KOSPI 200 June rebalancing and examines SK Bioscience's KOSPI 200 fast entry situation along with a likely...

Logo
515 Views
Share
bullishSK Bioscience
16 Mar 2021 08:40

Germany, France, Italy, & Spain Suspend AstraZeneca COVID-19 Vaccinations: Impact on SK Bioscience

While we remain bullish on the SK Bioscience IPO, the fact that 15 countries have decided to temporarily suspend AstraZeneca COVID-19 vaccines will...

Logo
300 Views
Share
bullishSK Bioscience
14 Mar 2021 13:04

SK Bioscience IPO: Allocation & Lockup Schedule

This post details SK Bioscience IPO's allocation results and lockup schedule (also the index float for KOSPI 200 fast-entry).

Logo
421 Views
Share
x